Novel selective PPARδ agonists: Optimization of activity by modification of alkynylallylic moiety

Bioorganic & Medicinal Chemistry Letters
2007.0

Abstract

Y-shaped molecules bearing alkynylallylic moieties were found to be potent and selective PPARdelta activators. The alkynylallylic moiety was synthesized from alkyn-1-ols by hydroalumination followed by a cross-coupling reaction. Series of active compounds 6 were obtained by stepwise changing the structure of the known PPARpan agonist 5 into Y-shaped compounds. The most active and selective compound, 6f, had a PPARdelta potency of 0.13 microM, which is 50-fold more potent than compound 5.

Knowledge Graph

Similar Paper

Novel selective PPARδ agonists: Optimization of activity by modification of alkynylallylic moiety
Bioorganic & Medicinal Chemistry Letters 2007.0
Novel selective small molecule agonists for peroxisome proliferator-activated receptor δ (PPARδ)—synthesis and biological activity
Bioorganic & Medicinal Chemistry Letters 2003.0
Design, synthesis, and biological evaluation of a series of alkoxy-3-indolylacetic acids as peroxisome proliferator-activated receptor γ/δ agonists
Bioorganic & Medicinal Chemistry 2015.0
Identification and Synthesis of a Novel Selective Partial PPARδ Agonist with Full Efficacy on Lipid Metabolism In Vitro and In Vivo
Journal of Medicinal Chemistry 2007.0
Selective, potent PPARγ agonists with cyclopentenone core structure
Bioorganic & Medicinal Chemistry Letters 2009.0
Indanylacetic Acid Derivatives Carrying 4-Thiazolyl-phenoxy Tail Groups, a New Class of Potent PPAR α/γ/δ Pan Agonists:  Synthesis, Structure−Activity Relationship, and In Vivo Efficacy
Journal of Medicinal Chemistry 2007.0
Design and synthesis of novel Y-shaped barbituric acid derivatives as PPARγ activators
European Journal of Medicinal Chemistry 2016.0
Discovery and structure-based design of a new series of potent and selective PPARδ agonists utilizing a virtual screening method
Bioorganic & Medicinal Chemistry Letters 2022.0
Design of potent PPARα agonists
Bioorganic & Medicinal Chemistry Letters 2007.0
2-Alkoxydihydrocinnamates as PPAR agonists. Activity modulation by the incorporation of phenoxy substituents
Bioorganic & Medicinal Chemistry Letters 2005.0